GeneDx Holdings WGS Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's common stock, shares authorized (in shares)?
- GeneDx Holdings (WGS) reported common stock, shares authorized (in shares) of $1B in Q1 2026.
- How has GeneDx Holdings's common stock, shares authorized (in shares) changed year-over-year?
- GeneDx Holdings's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $1B to $1B.
- What is the long-term trend for GeneDx Holdings's common stock, shares authorized (in shares)?
- Over 4 years (2021 to 2025), GeneDx Holdings's common stock, shares authorized (in shares) has grown at a 27.4% compound annual growth rate (CAGR), from $380M to $1B.